Announcement

Collapse
No announcement yet.

Androxal

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Androxal

    From the Dow Jones newswire.
    Repros Theraputics said its first study of Androxal showed the drug raised men's testosterone levels to a normal range. The study was done on men who had hypogonadism resulting in low testosterone levels. The study required 75% of the men to exhibit a 24 hour average testosterone level of 300 to 1040 ng/dl at the end of a 12 week treatment. 79% reached testosterone levels in the normal range. Repros stock jumped 70% to $15.53. The drug is still in the research stage.
    1700 years ago, supermen walked on earth. They called themselves Goths.
Working...
X